US Patent Issued to Hikma Pharmaceuticals USA on Jan. 20 for "Ready-to-administer hydromorphone formulations" (Ohio Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,787, issued on Jan. 20, was assigned to Hikma Pharmaceuticals USA Inc. (Eatontown, N.J.).

"Ready-to-administer hydromorphone formulations" was invented by Andrew Conrad (Bedford, Ohio) and Bernadette Colvard (Bedford, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a ready-to-administer (RTA), intravenous (IV) bag presentation for hydromorphone. In particular, the present disclosure relates to terminally sterilized liquid formulations comprising hydromorphone hydrochloride in sodium chloride packaged in an RTA IV bag. The present disclosure also relates to methods of treating patients by administration of such f...